Blog

America’s FTC Sues Insulin Middlemen Who ‘Artificially Inflated’ Drug Price

Friday America’s Federal Trade Commission brought action against three companies for “anticompetitive and unfair” practices “that have artificially inflated the list price of insulin.” For years, many of the millions of Americans who need insulin to survive “have been forced to pay exorbitant prices for a product that’s inexpensive to make,” writes NPR. “Now, the

Read More